Crick — Clinical Intelligence Platform

Not applicableStudy completedNCT03857997

What this trial is testing

Contribution of High Throughput RNA Sequencing Combined With Sequencing of Whole Genomes in the Diagnosis of Intellectual Disability

Who this might be right for

Patients With Intellectual Disabilities Without an Obvious Clinical DiagnosisPatients With Normal Array CGH and Previous Negative Genetic Investigations (WES-solo or WES-trio)

Centre Hospitalier Universitaire Dijon 62

Results for “TRIO”

TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)

Fast Exome for Diagnosis of Congenital Conditions in Infants Under 12 Months of Age Hospitalized in Intensive Care Unit

Comparison of Devices for Atrial Septal Defects Closure: A Pilot Study

Kosmos Trio and Ejection Fraction Pivotal Study

Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer

Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

Follow up of LEAP Participants and Their Families

Parental Irradiation of Ukrainian Cleanup Workers and Evacuees and Germline Mutations in Their Offspring (Trio Study)

Contribution of High Throughput RNA Sequencing Combined With Sequencing of Whole Genomes in the Diagnosis of Intellectual Disability

Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"

Time-Restricted Feeding

Study of the Value of Trio Exome Sequencing in the Etiological Assessment of Specific Non-syndromic Language and Learning Disorders

Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia

Three Fraction Radiation to Induce Immuno-Oncologic Response

Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer

Identification of the Genetic Causes of Rare Diseases With Negative Exome Findings

Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy